Mirtazapine
Product Images NDC 33261-074

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 33261-074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Mirtazapine (Mirtazapine Tab 30mg For Patheon 1)

Chemical Structure For Mirtazapine (Mirtazapine Tab 30mg For Patheon 1)
Chemical structure diagram of the active ingredient Mirtazapine, showing its molecular framework including nitrogen-containing rings and a methyl group.*
FDA Label Image

Image Label (Mirtazapine Tab 30mg For Patheon 2)

Image Label (Mirtazapine Tab 30mg For Patheon 2)
Label for Mirtazapine 30 mg film-coated tablets, containing 60 tablets per bottle, distributed by Aidarex Pharmaceuticals LLC. The label shows the active ingredient Mirtazapine 30 mg and notes packaging details, including the generic name Remeron and manufacturer Patheon Pharmaceuticals Inc., Cincinnati, OH.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.